Denali Capital extends business combination deadline to Dec 11, 2024 with $15,064 deposit

Semnur Pharmaceuticals, Inc.

Deposited $15,063.74 into trust account to extend deadline from Nov 11 to Dec 11, 2024.
Funding came from a convertible promissory note issued to Scilex Holding (SCLX) for up to $180,000.
Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share.
Remaining $119,772.04 under the note may fund future monthly extensions.
SPAC (DECA) is a blank-check company seeking a business combination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.